TaqMan PCR-based gene dosage assay for predictive testing in individuals from a cancer family with INK4 locus haploinsufficiency

Clinical Chemistry

Volumn 45, Issue 7, 1999, Pages 982-986

  Laurendeau, Ingrid ^a   Bahuau, Michel ^a   Vodovar, Nicolas ^a   Larramendy, Claire ^a   Olivi, Martine ^a   Bieche, Ivan ^a   Vidaud, Michel ^a   Vidaud, Dominique ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER FAMILY; DNA DETERMINATION; GENE DELETION; GENE DOSAGE; GENE LOCUS; HUMAN; MELANOMA; NERVOUS SYSTEM TUMOR; POLYMERASE CHAIN REACTION; PREDICTION;

EID: 0032798819     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/45.7.982     Document Type: Article

References (12)

1. Bahuau M, Vidaud D, Kujas M, Palangié A, Assouline B, Chaignaud-Lebreton M, et al. Familial aggregation of malignant melanoma/dysplastic naevi and tumours of the nervous system: an original syndrome of tumour proneness. Ann Genet 1997;40:78-91.
2. Bahuau M, Vidaud O, Jenkins RB, Bièche I, Kimmel DW, Assouline B, et al. Germ-line deletion involving the INK4 locus in familial proneness to melanoma and nervous system tumors. Cancer Res 1998;58:2298-303.
3. Holland PM, Abramson RD, Watson R, Gelfand DH. Detection of specific polymerase chain reaction product by utilizing the 5′ to 3′ exonuclease activity of Thermus aquaticus DNA polymerase. Proc Natl Acad Sci U S A 1991;88:7278-80.
4. Lie YS, Petropoulos CJ. Advances in quantitative PCR technology: 5′ nuclease assays. Curr Opin Biotechnol 1998;9:43-8.
5. Lo YMD, Tein MSC, Lau TK, Haines CJ, Leung TN, Poon PMK, et al. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet 1998;62:768-75.
6. Sambrook J, Fritsch EF, Maniatis T, eds. Molecular cloning: a laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989.
7. Cairns JP, Chiang PW, Ramamoorthy S, Kurnit DM, Sidransky D. A comparison between microsatellite and quantitative PCR analyses to detect frequent p16 copy number changes in primary bladder tumors. Clin Cancer Res 1998;4:441-4.
8. Petrij-Bosch A, Peelen T, van Vliet M, van Eijk R, Olmer R, Drusedeau M, et al. BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients. Nat Genet 1997;17:341-5.
9. Shen MH, Harper PS, Upadhyaya M. Molecular genetics of neurofibromatosis type 1 (NF1). J Med Genet 1996;33:2-17.
10. van Essen AJ, Kneppers AL, van der Hout AH, Scheffer H, Ginjaar IB, ten Kate LP, et al. The clinical and molecular genetic approach to Duchenne and Becker muscular dystrophy: an updated protocol. J Med Genet 1997;34:805-12.
11. Celi FS, Cohen MM, Antonarakis SE, Wertheimer E, Roth J, Shuldiner AR. Determination of gene dosage by a quantitative adaptation of the polymerase chain reaction (gd-PCR): rapid detection of deletions and duplications of gene sequences. Genomics 1994;21:304-10.
12. Verma L, Macdonald F, Leedham P, McConachie M, Dhanjal S, Hultén M. Rapid and simple prenatal DNA diagnosis of Down's syndrome. Lancet 1998;352:9-12.